Wave Life Sciences (WVE) Common Equity (2014 - 2026)
Wave Life Sciences (WVE) posted Common Equity of $511.7 million for Q1 2026, down 1.28% on a QoQ basis from $518.4 million in Q4 2025, and up 197.86% year-over-year from $171.8 million in Q1 2025.
Wave Life Sciences (WVE) Common Equity (2014 - 2026) Analysis & Trends
Wave Life Sciences' Common Equity history runs 13 years deep, the most recent figure standing at $511.7 million for Q1 2026.
- Quarterly Common Equity rose 197.86% year-over-year to $511.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $511.7 million (up 197.86% YoY) and the FY2025 annual result came in at $518.4 million, up 147.41% from the prior year.
- Common Equity was $511.7 million for Q1 2026 at Wave Life Sciences, down from $518.4 million in the prior quarter.
- Across five years, Common Equity topped out at $518.4 million in Q4 2025 and bottomed at -$51.7 million in Q2 2023.
- A 5-year average of $101.9 million and a median of $30.9 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity tumbled 65398.11% — and 2025, when it soared 4105.35%.
- Wave Life Sciences' Common Equity stood at -$45.1 million in 2022, then soared by 187.89% to $39.6 million in 2023, then jumped by 428.68% to $209.5 million in 2024, then soared by 147.41% to $518.4 million in 2025, then decreased by 1.28% to $511.7 million in 2026.
- Business Quant data shows WVE's Common Equity at $511.7 million in Q1 2026, $518.4 million in Q4 2025, and $124.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 511.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 511.73 Mn |
| Dec 31, 2025 | 518.36 Mn |
| Sep 30, 2025 | 124.55 Mn |
| Jun 30, 2025 | 139.27 Mn |
| Mar 31, 2025 | 171.80 Mn |
| Dec 31, 2024 | 209.52 Mn |
| Sep 30, 2024 | 141.64 Mn |
| Jun 30, 2024 | -3.48 Mn |
| Mar 31, 2024 | 25.39 Mn |
| Dec 31, 2023 | 39.63 Mn |
| Sep 30, 2023 | -40.49 Mn |
| Jun 30, 2023 | -51.72 Mn |
| Mar 31, 2023 | -34.71 Mn |
| Dec 31, 2022 | -45.09 Mn |
| Sep 30, 2022 | -4.52 Mn |
| Jun 30, 2022 | 30.95 Mn |
| Mar 31, 2022 | -53,000.00 |
| Dec 31, 2021 | 32.50 Mn |
| Sep 30, 2021 | 29.90 Mn |
| Jun 30, 2021 | 21.84 Mn |